REG - Indivior PLC - Indivior PLC Files 2024 Annual Report on Form 10-K

IndiviorAnnouncement

04/03/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250304:nRSD1820Za&default-theme=true

RNS Number : 1820Z  Indivior PLC  04 March 2025

Indivior PLC Files 2024 Annual Report on Form 10-K

Richmond, VA, March 4, 2025 - Indivior PLC (NASDAQ/LSE: INDV) filed its Annual
Report on Form 10-K for the year ended December 31, 2024, with the U.S.
Securities and Exchange Commission ("SEC") on March 3, 2025. The Annual Report
on Form 10-K is now available at www.sec.gov and under the "Investors" section
of the Company's website (www.indivior.com).

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat substance use disorders (SUD). Our
vision is that all patients around the world will have access to
evidence-based treatment for the chronic conditions and co-occurring disorders
of SUD. Indivior is dedicated to transforming SUD from a global human crisis
to a recognized and treated chronic disease. Building on its global portfolio
of OUD treatments, Indivior has a pipeline of product candidates designed to
expand on its heritage in this category. Headquartered in the United
States in Richmond, VA, Indivior employs over 1,000 individuals globally and
its portfolio of products is available in over 30 countries worldwide.
Visit www.indivior.com
(https://c212.net/c/link/?t=0&l=en&o=4271839-1&h=3117038971&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4245151-1%26h%3D1246464342%26u%3Dhttps%253A%252F%252Fwww.indivior.com%252Fen%26a%3Dwww.indivior.com&a=www.indivior.com)
 to learn more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior
(https://c212.net/c/link/?t=0&l=en&o=4271839-1&h=2950697406&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4245151-1%26h%3D27799095%26u%3Dhttp%253A%252F%252Fwww.linkedin.com%252Fcompany%252Findivior%26a%3Dwww.linkedin.com%252Fcompany%252Findivior.&a=www.linkedin.com%2Fcompany%2Findivior)
.

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKNBQCBKDANK